Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eplerenone timing and PAI-1 in metabolic syndrome
NCT00515021Phase 4Completed
- Sponsor
- Vanderbilt University Medical Center
- Start
- Apr 2007
- Primary completion
- Apr 2010
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of eplerenone in metabolic syndrome, sponsored by Vanderbilt University Medical Center. Started Apr 2007; status: completed.
02
Drugs
eplerenone
03
Conditions
metabolic syndrome
Beyond the preview
Go deeper on NCT00515021.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00515021.